Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2008;112:538-544
© 2008 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Thurman, A. R.
Right arrow Articles by Soper, D. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thurman, A. R.
Right arrow Articles by Soper, D. E.
Related Collections
Right arrow General gynecology
Right arrow Infectious disease

ORIGINAL RESEARCH

Methicillin-Resistant Staphylococcus aureus as a Common Cause of Vulvar Abscesses

Andrea Ries Thurman, MD1, Tiffany M. Satterfield, DO1 and David E. Soper, MD2

From the Departments of Obstetrics and Gynecology, 1University of Texas Health Sciences Center San Antonio, Texas; and 2Medical University of South Carolina, Charleston, South Carolina.

OBJECTIVE: To estimate the incidence of methicillin-resistant Staphylococcus aureus (MRSA) among women with vulvar abscesses and to describe clinical factors associated with inpatient compared with outpatient treatment.

METHODS: We reviewed all women with a vulvar abscess who were treated with incision and drainage between October 2006 to March 2008. We reviewed the abscess cultures and evaluated clinical and laboratory variables associated with inpatient compared with outpatient treatment.

RESULTS: During the 80-week study period, 162 women were treated for a vulvar abscess. Methicillin-resistant S aureus was isolated from 85 of 133 (64%) cultured vulvar abscesses. No presenting signs or symptoms were more common among patients with MRSA abscesses. Women with an MRSA vulvar abscess were not more likely to require inpatient admission or experience treatment complications. Inpatient treatment occurred in 64 of 162 (40%) patients and was predicted by medical comorbidities: diabetes (45.3%, odds ratio [OR] 2.29, 95% confidence interval [CI] 1.12–4.72), hypertension (34.4%, OR 2.33, 95% CI 1.06–5.13), initial serum glucose greater than 200 (37.5%, OR 3.32, 95% CI 1.48–7.51), and signs of worse infection, ie, larger abscesses (mean 5.2 cm) (P<.001) and elevated white blood cell count of at least 12,000/mm3 (45.3%, OR 3.04, 95% CI 1.44–6.43).

CONCLUSION: Methicillin-resistant S aureus was the most common organism isolated from vulvar abscesses. Inpatient treatment is more common in women with medical comorbidities, larger abscesses, and signs of systemic illness. An antibiotic regimen with activity against MRSA, such as trimethoprim-sulfamethoxazole, should be considered in similar populations with vulvar abscesses.

LEVEL OF EVIDENCE: III







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American College of Obstetricians and Gynecologists.